Natera, Inc. Common Stock (NTRA) is a publicly traded Healthcare sector company. As of August 19, 2026, NTRA trades at $311.25 with a market cap of $45.29B and a P/E ratio of -231.91. NTRA moved -0.79% today. Year to date, NTRA is +36.06%; over the trailing twelve months it is +93.42%. Its 52-week range spans $125.38 to $326.03. Analyst consensus is strong buy with an average price target of $335.58. Rallies surfaces NTRA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks NTRA insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $311.25 |
| Market Cap | $45.29B |
| P/E Ratio | -231.91 |
| EPS | $-1.35 |
| Dividend Yield | 0.00% |
| 52-Week High | $326.03 |
| 52-Week Low | $125.38 |
| Volume | 983.55K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.71B |
| Net Income | $-192.35M |
| Gross Margin | 0.00% |
20 analysts cover NTRA: 0 strong buy, 18 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $335.58.